Further bioinformatic analyses have highlighted the potential role of rare variants in interferon receptor genes IFNAR1 p.Val168Leu, is associated with a reduced risk of severe COVID-19, while rare pathogenic variants in both IFNAR1 and IFNAR2 may impair antiviral signaling. This evidence concerns the gene IFNAR1 and COVID-19.